

Clinical Need
Large arteriotomy management is a unique challenge.
A fully percutaneous approach has become the standard of care for most structural heart and aortic vascular procedures. There is increasing awareness that large catheter sizes can create unique challenges that require a dedicated closure solution.
Technology
Designed for
purpose

Suitable for arteriotomies up to 24F
No pre-procedural steps – OTW delivery
One device per arteriotomy
Fully synthetic absorbable implant
No sutures, no collagen, no metal
Simple and secure
device deployment

Automatic loading – Simple and intuitive delivery
Safety Guidewire remains in situ until implant release
Dedicated 0.035” compatible introducer
Patch based fully
absorbable implant

Ultra-low profile patch, rapidly endothelialised¹
Implant fully absorbed within 180 days¹
Abluminal surface matrix promotes adherence and healing¹
Implant fully absorbed within 180 days¹
Vessel remains patent - restored to its pre-procedure state

Implanted Patch

32
Days
Implant Fully Encapsulated

91
Days
Implant extra-vascular-vessel remodeling

180
Days
Implant fully absorbed - vessel restored
Clinical Evidence
Frontier clinical programmes - An evolving database of safety and effectiveness

References:
1. Pre-clinical data – on file at Vivasure Medical
2. Clinical data Frontier I-IV studies on file at Vivasure Medical
About Us
Vivasure Medical Limited is a highly innovative medical device company based in the heart of Europe’s largest medtech hub in Galway, Ireland. The company develops advanced polymer implants and delivery systems, primarily focused on minimally invasive vessel closure in cardiology, interventional radiology and vascular surgery.
Established in 2009, Vivasure operates a fully integrated, ISO 13485 certified, R&D and manufacturing facility. The company is staffed by an experienced team of medical device professionals with expertise spanning research, engineering, material science, quality, regulatory, manufacturing, clinical and commercial roles.
Management team

Chief Executive Officer

Co-founder and Chief Operational Officer

Co-founder and Chief Technical Officer

Chief Financial Officer

Chief Commercial Officer

VP Regulatory and Quality Affairs

Director Research and Development
Board of Directors

Chairman







Board Observer
Our Partners








News

Vivasure Medical Begins Clinical Evaluation of Next-Generation PerQseal+ Device
20 April 2021 – GALWAY, Ireland – Vivasure Medical® today announced the first patient was enrolled in the Frontier V study, a European multicenter study

Vivasure Medical Announces Andrew Glass as Chief Executive Officer
6 April 2021 – GALWAY, Ireland – Vivasure Medical® today announced Andrew Glass has assumed the role of Chief Executive Officer. Founder and former CEO

Vivasure Medical co-sponsors Learning Center session at LINC 2021
18 January 2021 – GALWAY, Ireland – Vivasure Medical® will co-sponsor a session focused on endovascular innovation at the Leipzig Interventional Course 2021 (25-29 January
Phone or Fax
Tel: +353 91 395 440
Fax: +353 91 395 399
Address
Parkmore Business Park West
Galway
Ireland
H91 V3KP